Target intelligence / Profile preview

Ferric iron (Fe3+) (Fe3+)

Target
Fe3+
Molecular classification
Metal ion, Inorganic compound, Other
01

Overview

Ferric iron (Fe3+) deposits refer to the accumulation of iron in its trivalent oxidation state within tissues, typically sequestered in storage proteins like ferritin or as insoluble hemosiderin aggregates (StatPearls, 2023). Iron is a vital micronutrient required for essential cellular functions, including oxygen transport in hemoglobin and electron transfer in the mitochondrial respiratory chain (NIH, 2023). However, when iron levels exceed the capacity of storage proteins, free ferric iron can participate in redox reactions that generate hydroxyl radicals, leading to lipid peroxidation and systemic organ damage (PubMed, 2022). This accumulation is a primary pathological feature in conditions such as hereditary hemochromatosis and secondary iron overload resulting from chronic blood transfusions in patients with thalassemia or sickle cell disease (NIDDK, 2023). Pharmacological management involves iron chelation therapy, where drugs like deferoxamine or deferasirox bind specifically to ferric iron to facilitate its mobilization and excretion (PubChem, 2023). Monitoring these deposits is critical in clinical practice to prevent complications such as cirrhosis, heart failure, and endocrine dysfunction (Mayo Clinic, 2023).

Other names
Iron (III)Ferric ionNon-heme ironTissue iron depositsHemosiderin ironTrivalent iron
02

Mechanism of action

Iron chelators bind to ferric iron (Fe3+) with high affinity, forming stable, water-soluble complexes that prevent the iron from participating in oxidative reactions and facilitate its excretion from the body (PubChem, 2023).

03

Biological functions

Oxygen transportElectron transportDNA synthesisRedox homeostasis
04

Disease associations

Hereditary hemochromatosisTransfusion-dependent thalassemiaSickle cell diseaseParkinson's diseaseAlzheimer's diseaseSideroblastic anemia
05

Safety considerations

NephrotoxicityHepatotoxicityAgranulocytosisGastrointestinal irritationDepletion of essential trace metals (e.g., zinc, copper)Ocular and auditory toxicity
06

Interacting drugs

Deferoxamine

2 more in the full profile.

07

Biomarkers

Serum ferritinTransferrin saturation (TSAT)Liver iron concentration (LIC)Myocardial T2* MRIMagnetic resonance imaging (MRI) R2*

Beyond the preview

Go deeper on Ferric iron (Fe3+) (Fe3+).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferric iron (Fe3+) (Fe3+).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call